Researchers at the University of California, Irvine, have identified a method to potentially reverse age-related vision loss by targeting the ELOVL2 aging gene and restoring essential fatty acids in the retina. Their study, published in Science Translational Medicine, reveals that supplementing with specific polyunsaturated fatty acids (PUFAs)—beyond just DHA—can enhance visual function and even reverse signs of cellular aging in murine models.

The significance of this research lies in its potential to address age-related macular degeneration (AMD) and other vision impairments linked to aging. As lipid metabolism declines with age, levels of very-long-chain polyunsaturated fatty acids (VLC-PUFAs) in the retina decrease, leading to deteriorating vision. By bypassing the limitations of the ELOVL2 enzyme, the researchers demonstrated that targeted fatty acid supplementation could restore visual performance in older mice, suggesting a novel therapeutic approach. Notably, the study emphasizes that DHA alone is insufficient for these improvements, highlighting the importance of other fatty acids in maintaining retinal health.

This work shifts the paradigm in aging research by positioning ELOVL2 as a critical target for anti-aging therapies, particularly in ocular health. The findings could accelerate the development of targeted interventions for those at risk of vision loss, driven by genetic factors linked to ELOVL2. Furthermore, the implications extend beyond vision; ongoing investigations into lipid metabolism may reveal connections to immune aging, indicating that fatty acid supplementation could also enhance immune function and combat age-related diseases.

Source: sciencedaily.com